The U.S. Securities and Exchange Commission (SEC) is signaling support for streamlined “minimum effective dose” disclosure rules and tightly scoped equity‑tokenization pilots via an innovation exemption, according to new remarks from Chair Paul S. Atkins. The U.S. Securities and Exchange…News, Cryptocurrency, DeFi, ExchangeRead More

You might also be interested in reading Sintx Technologies files to sell 541,450 shares of common stock for holders.